FDA Adverse Event Injury Summary report: N

HEARTMATE 3 LVAS IMPLANT KIT

MDR report key: 11302691 · Received February 9, 2021

Report

Report Number
2916596-2021-00266
Event Type
Injury
Date Received
February 9, 2021
Date of Event
January 14, 2021
Report Date
February 9, 2021
Manufacturer
THORATEC CORPORATION
Product Code
DSQ
UDI-DI
00813024013297
PMA / PMN Number
P160054
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
OH, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

MANUFACTURER'S INVESTIGATION CONCLUSION: A DIRECT CORRELATION BETWEEN HEARTMATE 3 LVAS, SERIAL NUMBER (B)(4), AND THE REPORTED EVENTS COULD NOT BE CONCLUSIVELY ESTABLISHED THROUGH THIS EVALUATION. THE PATIENT REMAINS ONGOING ON HEARTMATE 3 LVAS, SERIAL NUMBER (B)(4). THE HEARTMATE 3 LVAS IFU, REV. C, IS CURRENTLY AVAILABLE. SECTION 1 OF THIS IFU LISTS BLEEDING AS AN ADVERSE EVENT THAT MAY BE ASSOCIATED WITH THE USE OF HEARTMATE 3 LEFT VENTRICULAR ASSIST SYSTEM. THIS DOCUMENT ALSO PROVIDES INFORMATION REGARDING ANTICOAGULATION, INCLUDING RECOMMENDED INR VALUES. THE RELEVANT SECTIONS OF THE DEVICE HISTORY RECORDS FOR MLP-023639 WERE REVIEWED AND SHOWED NO DEVIATIONS FROM MANUFACTURING OR QUALITY ASSURANCE SPECIFICATIONS. THE IMPLANT KIT WAS SHIPPED ON 20NOV2020. NO FURTHER INFORMATION WAS PROVIDED. THE MANUFACTURER IS CLOSING THE FILE ON THIS EVENT.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT WAS ADMITTED TO THE HOSPITAL WITH A HEMOGLOBIN RESULT OF 6.9 G/DL AFTER A ROUTINE OUTPATIENT LAB DRAW. ALL DIAGNOSTIC TESTING AND ESOPHAGOGASTRODUODENOSCOPY (EGD) WERE NEGATIVE. THE CAUSE OF BLEEDING WAS RELATED TO AN ELEVATED INTERNATIONAL NORMALIZED RATIO OF 4.9. NO OTHER SOURCE OF BLEEDING WAS IDENTIFIED. THE PATIENT WAS TREATED WITH 2 UNITS OF PACKED RED BLOOD CELLS (PRBCS) AND THE PATIENT'S DAILY DOSE OF COUMADIN WAS REDUCED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
200103 HEARTMATE 3 LVAS IMPLANT KIT VENTRICULAR (ASSISST) BYPASS DSQ THORATEC CORPORATION 106524US 7666872 00813024013297

Patients

Seq Age Sex Outcome Treatment
1 44 YR Hospitalization